MedPath

Gamified Acceptance & Commitment Therapy for Benzodiazepine Discontinuation: Randomised controlled trial

Not Applicable
Conditions
Benzodiazepine Discontinuation
Registration Number
JPRN-UMIN000023580
Lead Sponsor
agoya City University Graduate School of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1.Being regulary prescribed 3 types of benzodiazepine and over. (excluded required use or use for insomnia) 2.Actively satisfied diagnostic cliteria with Mini-International Neuropsychiatric Interview. 3.Being regularly prescribed antipsychotic or mood stabilizer (lithium, valproate, carbamazepine and lamotrigine) 4.Imminent risk of suicide as judged by the treating physician. 5.Currently participating in another clinical intervention study. 6. Family members living with the researchers of the present study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The success rate of benzodiazepine discontinuation during the 11th and 12th week after beginning of the program
Secondary Outcome Measures
NameTimeMethod
Benzodiazepine reduction rate,Recovery Assessment Scale(RAS),Depression Anxiety Stress Scale(DASS),Severity of Dependence syndrome(SDS),Euro Qol 5 Dimension(EQ5-D),Cognitive Fusion Questionnaire(CFQ),Personal Values Questionnaire II (PVQ-II)
© Copyright 2025. All Rights Reserved by MedPath